Neus Bota-Rabassedas

4PUBLICATIONS
54CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma.

|Apr 08, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC.

Pedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca

|Nov 04, 2021
The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cells.

Priyam Banerjee, Guan-Yu Xiao, Xiaochao Tan

|Apr 20, 2021
A collagen glucosyltransferase drives lung adenocarcinoma progression in mice.

Hou-Fu Guo, Neus Bota-Rabassedas, Masahiko Terajima

Pageof 1

Frequent Collaborators

2 joint publications

Chad J Creighton

2 joint publications

Jonathan M Kurie

1 joint publications

Lixia Diao

1 joint publications

Jing Wang